Sila Realty Trust, Inc.: directors' dealings · United States · SEC (Form 4)

About Sila Realty Trust, Inc.

Sila Realty Trust, Inc. is a U.S.-based real estate investment trust listed on the NYSE under the ticker SILA, with headquarters in Tampa, Florida, United States. For French, Belgian and Swiss investors, the company is best understood as a specialized healthcare REIT focused on net-lease real estate, a defensive listed property segment. Its business model is built around owning long-duration leased properties and generating relatively predictable rental income from healthcare operators, which typically provides more stability than more cyclical real estate categories. Sila’s corporate history reflects a gradual strategic repositioning toward necessity-based healthcare assets. While the company has had a broader net-lease heritage in the past, including exposure to data centers and other property types, its current investment thesis is clearly centered on healthcare infrastructure. The company describes itself as a net lease REIT with a strategic focus on the growing and resilient healthcare sector of the U.S. economy. Its core activities are straightforward: acquiring, owning and managing healthcare-related properties, while also selectively providing financing for development opportunities tied to care delivery. The portfolio includes medical office buildings, surgery centers, hospitals, inpatient rehabilitation facilities, long-term acute care hospitals, behavioral health assets and other essential care facilities. This asset mix gives Sila exposure to secular demand drivers such as aging demographics, the continued shift toward outpatient and specialized care, and the need for locally accessible medical services. From a competitive standpoint, Sila stands out through portfolio diversification, tenant quality discipline and a focus on essential-services operators. Recent company disclosures indicate a portfolio of roughly 137 to 140 properties and about 5.3 million rentable square feet, spread across multiple U.S. markets. That geographic diversification helps reduce local concentration risk and supports more resilient cash generation. The company’s net-lease structure, typically with long lease terms and tenant responsibility for most property-level expenses, further enhances earnings visibility. Recent highlights matter for investors. Sila reported full-year 2025 results and first-quarter 2026 results, while continuing to recycle capital through acquisitions and selective sales. More importantly, in April 2026 the company announced a $2.4 billion acquisition agreement with affiliates of Blue Owl. If completed, the deal would take Sila private and result in the stock being delisted from the NYSE. That makes SILA a particularly notable name at the intersection of defensive healthcare real estate and a major near-term corporate event in the United States market.